Sumanta (Monty) Pal, MD, FASCO, Vice Chair of Academic Affairs in the Department of Medical Oncology & Therapeutic Research at City of Hope, has been announced as a candidate for the American Society of Clinical Oncology (ASCO) Board of Directors in the Undesignated Member category.
The position carries a four-year term and represents an opportunity to contribute to the Society’s leadership, governance, and strategic direction.
With a professional background spanning academic oncology, cancer genomics, scientific communication, and mentorship, Dr. Pal has maintained an active role in ASCO through committee service, educational initiatives, and programs supporting the next generation of oncology professionals.
His contributions include leadership within ASCO’s Cancer Communications Committee, participation in the Annual Meeting Scientific Program Committee, and involvement in several national and international mentorship programs.
Academic Leadership at City of Hope
Dr. Pal currently serves as Vice Chair of Academic Affairs for the Department of Medical Oncology & Therapeutic Research at City of Hope.
He also holds an appointment as Adjunct Professor in the Division of Integrated Cancer Genomics at the Translational Genomics Research Institute (TGen).
These positions connect academic medical oncology with cancer genomics, two areas that continue to influence the development of modern cancer treatment.
As molecular profiling and precision medicine become increasingly integrated into clinical practice, collaboration between clinical oncology and genomic research remains essential to understanding tumor biology and identifying potential therapeutic approaches.
Dr. Pal’s appointments reflect his involvement in both academic oncology and the broader research environment supporting advances in cancer medicine.
His responsibilities at City of Hope also place him within the academic leadership of a major cancer research and treatment institution.
A Longstanding Role in ASCO Leadership
Dr. Pal has held several volunteer positions within ASCO, contributing to the Society’s scientific, educational, and organizational activities.
He previously served as Chair of the Cancer Communications Committee, a role associated with the communication of oncology information to professional and broader audiences.
He has also served as a member of the ASCO Nominating Committee, participating in an important component of the Society’s leadership selection process.
In addition, Dr. Pal has been a member of the Annual Meeting Scientific Program Committee, contributing to activities associated with the scientific content of ASCO’s flagship annual conference.
The ASCO Annual Meeting brings together oncology professionals from around the world to present research findings, discuss developments in cancer treatment, and examine emerging challenges across oncology specialties.
Through these committee appointments, Dr. Pal has participated in several aspects of the Society’s work, from scientific programming and professional communication to organizational governance.
Bringing Oncology Research to a Wider Audience
Scientific communication has been a notable component of Dr. Pal’s involvement with ASCO.
He previously served as an Associate Editor of Cancer.Net, ASCO’s patient information platform, which provides accessible, evidence-based information about cancer diagnosis, treatment, and supportive care.
His work with Cancer.Net connected oncology expertise with the need to communicate complex medical information clearly to patients and their families.
Dr. Pal currently hosts the ASCO Daily News Podcast, a platform featuring discussions about cancer research, clinical developments, and issues affecting the oncology community.
Through the podcast, he participates in conversations that help bring scientific findings and professional perspectives to clinicians, researchers, and other audiences interested in oncology.
These roles reflect the growing importance of effective scientific communication at a time when new research findings, treatment approaches, and clinical data are continually changing the field.
For oncology professionals, access to reliable scientific information is an essential part of continuing education and evidence-based clinical practice.
Mentorship Across Borders and Career Stages
Beyond his academic and communication roles, Dr. Pal has been extensively involved in mentorship initiatives supporting oncology professionals at different stages of their careers.
He served as a mentor in the ASCO Leadership Development Program for two consecutive years, contributing to an initiative designed to develop leadership skills among emerging oncology professionals.
His mentorship activities have also included participation in the ASCO International Development & Education Award (IDEA) program, which provides educational and professional development opportunities for oncology professionals from around the world.
Dr. Pal has additionally served as a mentor through the ASCO Virtual Mentoring Program, the ASCO–Japanese Society of Clinical Oncology (JSCO) Fellowship Program, and the ASCO Oncology Summer Internship.
These initiatives address different stages of professional development, from early exposure to oncology to international educational exchange and leadership training.
His participation across multiple programs reflects a sustained commitment to supporting professional growth within the oncology community.
Supporting the Next Generation of Cancer Researchers
Dr. Pal’s mentorship has also extended to early-career researchers pursuing competitive research funding.
He has mentored several successful recipients of ASCO Career Development Awards and Young Investigator Awards.
These awards, supported through Conquer Cancer, the ASCO Foundation, provide funding opportunities intended to help investigators establish and advance their research careers.
The Young Investigator Award supports early-career oncology researchers, while the Career Development Award is designed to assist investigators as they develop independent research programs.
Mentorship can play an important role in these stages of an academic career, particularly in developing research proposals, navigating professional opportunities, and building long-term scientific collaborations.
Dr. Pal’s involvement with successful award recipients adds another dimension to his contributions to oncology education and research development.
Connecting Scientific Communication, Research, and Leadership
The Undesignated Member position on the ASCO Board of Directors is not restricted to a particular oncology specialty, allowing candidates to contribute perspectives from different areas of cancer medicine and professional practice.
Dr. Pal’s background brings together several areas of relevance to the Society’s work.
His academic appointments connect him with medical oncology and cancer genomics, while his ASCO committee service includes experience in scientific programming, communications, and leadership selection.
His work with Cancer.Net and the ASCO Daily News Podcast demonstrates involvement in communicating oncology information to different audiences.
At the same time, his participation in mentorship programs reflects engagement with professional development, international education, and the support of early-career researchers.
Together, these activities provide a broad professional background for potential service on the ASCO Board of Directors.
A New Chapter in ASCO Leadership
Dr. Sumanta (Monty) Pal’s candidacy for the four-year Board of Directors term represents a potential extension of his longstanding involvement with ASCO.
From his academic leadership at City of Hope and appointment at TGen to his work in scientific communication and mentorship, his career has connected several important dimensions of oncology.
His previous service on the Cancer Communications Committee, Nominating Committee, and Annual Meeting Scientific Program Committee, alongside his current role hosting the ASCO Daily News Podcast, reflects continued engagement with the Society’s activities.
If elected, Dr. Pal would bring experience in academic medicine, cancer genomics, oncology communications, and professional mentorship to the ASCO Board of Directors.
The election will determine the next representative for the Undesignated Member seat as ASCO prepares for its upcoming leadership term.
Discover more articles like this on OncoDaily.